Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0443 Transporter Info | ||||
Gene Name | SLC6A11 | ||||
Transporter Name | Sodium- and chloride-dependent GABA transporter 3 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Pancretic ductal adenocarcinoma |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A11 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg25320780) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.28E+00 | Statistic Test | p-value:3.84E-07; Z-score:-1.63E+00 | ||
Methylation in Case |
4.73E-01 (Median) | Methylation in Control | 6.05E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A11 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg17537007) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.03E-04; Z-score:-3.48E-01 | ||
Methylation in Case |
8.62E-01 (Median) | Methylation in Control | 8.74E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC6A11 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg20208384) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.13E+00 | Statistic Test | p-value:6.92E-03; Z-score:-7.53E-01 | ||
Methylation in Case |
1.30E-01 (Median) | Methylation in Control | 1.46E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC6A11 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg06808585) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.92E+00 | Statistic Test | p-value:1.80E-11; Z-score:-2.19E+00 | ||
Methylation in Case |
2.38E-01 (Median) | Methylation in Control | 4.57E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC6A11 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg24237813) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.08E+00 | Statistic Test | p-value:1.25E-04; Z-score:-1.10E+00 | ||
Methylation in Case |
3.59E-01 (Median) | Methylation in Control | 3.86E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC6A11 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS200 (cg07808555) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:3.34E+00 | Statistic Test | p-value:5.63E-44; Z-score:6.78E+00 | ||
Methylation in Case |
3.92E-01 (Median) | Methylation in Control | 1.17E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC6A11 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS200 (cg13432451) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:3.10E-08; Z-score:3.82E-01 | ||
Methylation in Case |
6.73E-02 (Median) | Methylation in Control | 6.05E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC6A11 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
TSS200 (cg21080921) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.17E+00 | Statistic Test | p-value:4.15E-05; Z-score:-8.06E-01 | ||
Methylation in Case |
4.55E-01 (Median) | Methylation in Control | 5.32E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC6A11 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
1stExon (cg02854695) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.96E+00 | Statistic Test | p-value:1.08E-16; Z-score:1.37E+00 | ||
Methylation in Case |
1.24E-01 (Median) | Methylation in Control | 6.33E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC6A11 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg18597991) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.15E+00 | Statistic Test | p-value:5.93E-09; Z-score:-1.67E+00 | ||
Methylation in Case |
7.25E-01 (Median) | Methylation in Control | 8.35E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC6A11 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg13459035) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.13E+00 | Statistic Test | p-value:7.66E-07; Z-score:-1.48E+00 | ||
Methylation in Case |
6.18E-01 (Median) | Methylation in Control | 7.00E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC6A11 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
Body (cg18886814) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:2.10E-03; Z-score:-8.54E-01 | ||
Methylation in Case |
4.96E-01 (Median) | Methylation in Control | 5.19E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC6A11 in pancretic ductal adenocarcinoma | [ 1 ] | |||
Location |
3'UTR (cg26960896) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.26E+00 | Statistic Test | p-value:1.85E-07; Z-score:-2.08E+00 | ||
Methylation in Case |
2.78E-01 (Median) | Methylation in Control | 3.51E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A11 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg09395732) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.27E+00 | Statistic Test | p-value:9.06E-06; Z-score:-8.57E+00 | ||
Methylation in Case |
6.15E-01 (Median) | Methylation in Control | 7.79E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A11 in bladder cancer | [ 2 ] | |||
Location |
Body (cg12461092) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.23E+00 | Statistic Test | p-value:1.94E-03; Z-score:-5.10E+00 | ||
Methylation in Case |
5.96E-01 (Median) | Methylation in Control | 7.34E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC6A11 in bladder cancer | [ 2 ] | |||
Location |
Body (cg04746240) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:1.54E-02; Z-score:-9.76E-01 | ||
Methylation in Case |
8.76E-01 (Median) | Methylation in Control | 8.91E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC6A11 in bladder cancer | [ 2 ] | |||
Location |
Body (cg15284635) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.18E+00 | Statistic Test | p-value:3.97E-02; Z-score:2.40E+00 | ||
Methylation in Case |
4.28E-01 (Median) | Methylation in Control | 3.62E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
15 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A11 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg18290624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.56E+00 | Statistic Test | p-value:2.34E-08; Z-score:1.54E+00 | ||
Methylation in Case |
1.99E-01 (Median) | Methylation in Control | 1.28E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A11 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg09395732) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:5.07E-08; Z-score:-1.65E+00 | ||
Methylation in Case |
7.81E-01 (Median) | Methylation in Control | 8.25E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC6A11 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg07744841) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.65E+00 | Statistic Test | p-value:2.91E-06; Z-score:1.36E+00 | ||
Methylation in Case |
1.09E-01 (Median) | Methylation in Control | 6.57E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC6A11 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg00605982) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.19E+00 | Statistic Test | p-value:9.90E-05; Z-score:7.17E-01 | ||
Methylation in Case |
1.31E-01 (Median) | Methylation in Control | 1.10E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC6A11 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg21123160) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.63E+00 | Statistic Test | p-value:6.28E-08; Z-score:1.52E+00 | ||
Methylation in Case |
2.63E-01 (Median) | Methylation in Control | 1.61E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC6A11 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg22331862) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.36E+00 | Statistic Test | p-value:1.40E-05; Z-score:8.51E-01 | ||
Methylation in Case |
2.47E-01 (Median) | Methylation in Control | 1.82E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC6A11 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg26836233) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.14E+00 | Statistic Test | p-value:7.94E-04; Z-score:5.06E-01 | ||
Methylation in Case |
1.42E-01 (Median) | Methylation in Control | 1.25E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC6A11 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg10527010) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.37E+00 | Statistic Test | p-value:1.42E-03; Z-score:6.14E-01 | ||
Methylation in Case |
1.08E-01 (Median) | Methylation in Control | 7.88E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC6A11 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg09022422) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.25E+00 | Statistic Test | p-value:2.13E-02; Z-score:2.27E-01 | ||
Methylation in Case |
5.09E-02 (Median) | Methylation in Control | 4.07E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC6A11 in breast cancer | [ 3 ] | |||
Location |
1stExon (cg16435571) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:1.58E-03; Z-score:1.48E-01 | ||
Methylation in Case |
3.92E-02 (Median) | Methylation in Control | 3.59E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC6A11 in breast cancer | [ 3 ] | |||
Location |
Body (cg12461092) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.18E+00 | Statistic Test | p-value:3.74E-07; Z-score:-1.65E+00 | ||
Methylation in Case |
5.94E-01 (Median) | Methylation in Control | 7.03E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC6A11 in breast cancer | [ 3 ] | |||
Location |
Body (cg09660365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.21E+00 | Statistic Test | p-value:2.56E-05; Z-score:7.64E-01 | ||
Methylation in Case |
2.83E-01 (Median) | Methylation in Control | 2.34E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC6A11 in breast cancer | [ 3 ] | |||
Location |
Body (cg14788003) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.18E+00 | Statistic Test | p-value:5.05E-05; Z-score:-8.54E-01 | ||
Methylation in Case |
6.36E-01 (Median) | Methylation in Control | 7.50E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon14 |
Methylation of SLC6A11 in breast cancer | [ 3 ] | |||
Location |
Body (cg04746240) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:7.34E-05; Z-score:-1.06E+00 | ||
Methylation in Case |
8.69E-01 (Median) | Methylation in Control | 8.85E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon15 |
Methylation of SLC6A11 in breast cancer | [ 3 ] | |||
Location |
Body (cg15668533) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:1.03E-02; Z-score:4.20E-01 | ||
Methylation in Case |
2.86E-01 (Median) | Methylation in Control | 2.66E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Celiac disease |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A11 in celiac disease | [ 4 ] | |||
Location |
TSS1500 (cg00605982) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.60E+00 | Statistic Test | p-value:2.72E-02; Z-score:9.83E-01 | ||
Methylation in Case |
9.16E-02 (Median) | Methylation in Control | 5.74E-02 (Median) | ||
Studied Phenotype |
Celiac disease[ ICD-11:DA95] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A11 in celiac disease | [ 4 ] | |||
Location |
Body (cg12461092) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.12E+00 | Statistic Test | p-value:3.42E-02; Z-score:-8.49E-01 | ||
Methylation in Case |
6.99E-01 (Median) | Methylation in Control | 7.83E-01 (Median) | ||
Studied Phenotype |
Celiac disease[ ICD-11:DA95] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
12 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A11 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg07744841) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.52E+00 | Statistic Test | p-value:2.70E-07; Z-score:2.00E+00 | ||
Methylation in Case |
1.25E-01 (Median) | Methylation in Control | 4.98E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A11 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg18290624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.70E+00 | Statistic Test | p-value:6.98E-07; Z-score:1.77E+00 | ||
Methylation in Case |
1.49E-01 (Median) | Methylation in Control | 8.75E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC6A11 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg00605982) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.67E+00 | Statistic Test | p-value:1.78E-05; Z-score:1.16E+00 | ||
Methylation in Case |
9.88E-02 (Median) | Methylation in Control | 5.91E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC6A11 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg09395732) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:2.08E-02; Z-score:1.02E+00 | ||
Methylation in Case |
9.24E-01 (Median) | Methylation in Control | 8.66E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC6A11 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS200 (cg22331862) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.86E+00 | Statistic Test | p-value:2.81E-13; Z-score:2.77E+00 | ||
Methylation in Case |
3.78E-01 (Median) | Methylation in Control | 2.03E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC6A11 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS200 (cg21123160) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.14E+00 | Statistic Test | p-value:1.13E-12; Z-score:2.68E+00 | ||
Methylation in Case |
3.84E-01 (Median) | Methylation in Control | 1.80E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC6A11 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS200 (cg26836233) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.49E+00 | Statistic Test | p-value:7.91E-04; Z-score:9.08E-01 | ||
Methylation in Case |
1.21E-01 (Median) | Methylation in Control | 8.15E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC6A11 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS200 (cg10527010) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.38E+00 | Statistic Test | p-value:4.51E-03; Z-score:6.35E-01 | ||
Methylation in Case |
8.19E-02 (Median) | Methylation in Control | 5.91E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC6A11 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
TSS200 (cg09022422) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.43E+00 | Statistic Test | p-value:1.40E-02; Z-score:3.78E-01 | ||
Methylation in Case |
3.46E-02 (Median) | Methylation in Control | 2.42E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC6A11 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
1stExon (cg16435571) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.08E+00 | Statistic Test | p-value:5.17E-04; Z-score:1.20E+00 | ||
Methylation in Case |
5.08E-02 (Median) | Methylation in Control | 2.44E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC6A11 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
Body (cg09660365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.63E+00 | Statistic Test | p-value:2.11E-06; Z-score:1.94E+00 | ||
Methylation in Case |
2.33E-01 (Median) | Methylation in Control | 1.43E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC6A11 in clear cell renal cell carcinoma | [ 5 ] | |||
Location |
Body (cg15668533) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.20E+00 | Statistic Test | p-value:5.81E-04; Z-score:8.89E-01 | ||
Methylation in Case |
2.53E-01 (Median) | Methylation in Control | 2.11E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
12 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A11 in colon adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg15081220) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.81E+00 | Statistic Test | p-value:2.34E-06; Z-score:4.63E+00 | ||
Methylation in Case |
6.79E-01 (Median) | Methylation in Control | 3.76E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A11 in colon adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg25804018) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.04E+00 | Statistic Test | p-value:7.04E-04; Z-score:4.78E+00 | ||
Methylation in Case |
1.52E-01 (Median) | Methylation in Control | 7.46E-02 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC6A11 in colon adenocarcinoma | [ 6 ] | |||
Location |
TSS200 (cg04285869) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.15E+00 | Statistic Test | p-value:1.30E-04; Z-score:-2.24E+00 | ||
Methylation in Case |
5.79E-01 (Median) | Methylation in Control | 6.65E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC6A11 in colon adenocarcinoma | [ 6 ] | |||
Location |
1stExon (cg24415208) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.31E+00 | Statistic Test | p-value:6.78E-07; Z-score:1.85E+00 | ||
Methylation in Case |
6.74E-01 (Median) | Methylation in Control | 5.16E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC6A11 in colon adenocarcinoma | [ 6 ] | |||
Location |
1stExon (cg10671668) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.93E+00 | Statistic Test | p-value:1.11E-05; Z-score:2.87E+00 | ||
Methylation in Case |
6.21E-01 (Median) | Methylation in Control | 3.21E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC6A11 in colon adenocarcinoma | [ 6 ] | |||
Location |
Body (cg18705155) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.68E+00 | Statistic Test | p-value:4.69E-09; Z-score:-3.79E+00 | ||
Methylation in Case |
3.76E-01 (Median) | Methylation in Control | 6.29E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC6A11 in colon adenocarcinoma | [ 6 ] | |||
Location |
Body (cg18677871) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:7.05E-09; Z-score:1.66E+00 | ||
Methylation in Case |
6.61E-01 (Median) | Methylation in Control | 5.95E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC6A11 in colon adenocarcinoma | [ 6 ] | |||
Location |
Body (cg14224444) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.41E+00 | Statistic Test | p-value:1.07E-06; Z-score:-2.32E+00 | ||
Methylation in Case |
4.23E-01 (Median) | Methylation in Control | 5.99E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC6A11 in colon adenocarcinoma | [ 6 ] | |||
Location |
Body (cg26890189) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.20E+00 | Statistic Test | p-value:1.18E-04; Z-score:1.33E+00 | ||
Methylation in Case |
5.32E-01 (Median) | Methylation in Control | 4.45E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC6A11 in colon adenocarcinoma | [ 6 ] | |||
Location |
Body (cg17864405) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:2.11E-03; Z-score:-1.18E+00 | ||
Methylation in Case |
7.39E-01 (Median) | Methylation in Control | 7.94E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC6A11 in colon adenocarcinoma | [ 6 ] | |||
Location |
3'UTR (cg07501827) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.13E+00 | Statistic Test | p-value:1.57E-04; Z-score:-1.65E+00 | ||
Methylation in Case |
5.97E-01 (Median) | Methylation in Control | 6.73E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC6A11 in colon adenocarcinoma | [ 6 ] | |||
Location |
3'UTR (cg06566678) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:3.04E-03; Z-score:-7.76E-01 | ||
Methylation in Case |
8.21E-01 (Median) | Methylation in Control | 8.36E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
15 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A11 in colorectal cancer | [ 7 ] | |||
Location |
TSS1500 (cg07744841) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.01E+00 | Statistic Test | p-value:2.22E-13; Z-score:2.93E+00 | ||
Methylation in Case |
5.50E-01 (Median) | Methylation in Control | 2.74E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A11 in colorectal cancer | [ 7 ] | |||
Location |
TSS1500 (cg18290624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.81E+00 | Statistic Test | p-value:8.18E-12; Z-score:2.61E+00 | ||
Methylation in Case |
5.84E-01 (Median) | Methylation in Control | 3.23E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC6A11 in colorectal cancer | [ 7 ] | |||
Location |
TSS1500 (cg00605982) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.55E+00 | Statistic Test | p-value:5.91E-11; Z-score:2.52E+00 | ||
Methylation in Case |
6.57E-01 (Median) | Methylation in Control | 4.25E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC6A11 in colorectal cancer | [ 7 ] | |||
Location |
TSS1500 (cg09395732) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:3.76E-03; Z-score:-3.71E-01 | ||
Methylation in Case |
9.03E-01 (Median) | Methylation in Control | 9.09E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC6A11 in colorectal cancer | [ 7 ] | |||
Location |
TSS200 (cg09022422) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.61E+00 | Statistic Test | p-value:4.23E-18; Z-score:3.70E+00 | ||
Methylation in Case |
4.23E-01 (Median) | Methylation in Control | 1.62E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC6A11 in colorectal cancer | [ 7 ] | |||
Location |
TSS200 (cg10527010) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.03E+00 | Statistic Test | p-value:3.67E-14; Z-score:3.01E+00 | ||
Methylation in Case |
4.95E-01 (Median) | Methylation in Control | 2.44E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC6A11 in colorectal cancer | [ 7 ] | |||
Location |
TSS200 (cg26836233) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.59E+00 | Statistic Test | p-value:6.47E-12; Z-score:2.53E+00 | ||
Methylation in Case |
6.77E-01 (Median) | Methylation in Control | 4.25E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC6A11 in colorectal cancer | [ 7 ] | |||
Location |
TSS200 (cg22331862) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.33E+00 | Statistic Test | p-value:1.28E-06; Z-score:1.40E+00 | ||
Methylation in Case |
6.10E-01 (Median) | Methylation in Control | 4.60E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC6A11 in colorectal cancer | [ 7 ] | |||
Location |
TSS200 (cg21123160) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.35E+00 | Statistic Test | p-value:2.67E-06; Z-score:1.41E+00 | ||
Methylation in Case |
6.21E-01 (Median) | Methylation in Control | 4.62E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC6A11 in colorectal cancer | [ 7 ] | |||
Location |
1stExon (cg16435571) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:3.36E+00 | Statistic Test | p-value:6.46E-18; Z-score:4.43E+00 | ||
Methylation in Case |
4.10E-01 (Median) | Methylation in Control | 1.22E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC6A11 in colorectal cancer | [ 7 ] | |||
Location |
Body (cg12461092) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.35E+00 | Statistic Test | p-value:2.67E-15; Z-score:-7.44E+00 | ||
Methylation in Case |
5.81E-01 (Median) | Methylation in Control | 7.87E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC6A11 in colorectal cancer | [ 7 ] | |||
Location |
Body (cg14788003) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.22E+00 | Statistic Test | p-value:2.19E-14; Z-score:-5.71E+00 | ||
Methylation in Case |
6.95E-01 (Median) | Methylation in Control | 8.50E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC6A11 in colorectal cancer | [ 7 ] | |||
Location |
Body (cg09660365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.31E+00 | Statistic Test | p-value:2.90E-05; Z-score:1.27E+00 | ||
Methylation in Case |
6.03E-01 (Median) | Methylation in Control | 4.59E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon14 |
Methylation of SLC6A11 in colorectal cancer | [ 7 ] | |||
Location |
Body (cg15668533) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.16E+00 | Statistic Test | p-value:1.49E-03; Z-score:9.24E-01 | ||
Methylation in Case |
6.80E-01 (Median) | Methylation in Control | 5.86E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon15 |
Methylation of SLC6A11 in colorectal cancer | [ 7 ] | |||
Location |
Body (cg04746240) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:1.10E-02; Z-score:-4.73E-01 | ||
Methylation in Case |
9.49E-01 (Median) | Methylation in Control | 9.52E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
23 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS1500 (cg26622895) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.63E+00 | Statistic Test | p-value:1.20E-17; Z-score:-3.79E+00 | ||
Methylation in Case |
4.03E-01 (Median) | Methylation in Control | 6.56E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS1500 (cg02505749) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:5.24E+00 | Statistic Test | p-value:4.59E-16; Z-score:6.77E+00 | ||
Methylation in Case |
3.51E-01 (Median) | Methylation in Control | 6.69E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS1500 (cg07744841) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.93E+00 | Statistic Test | p-value:1.75E-07; Z-score:3.70E+00 | ||
Methylation in Case |
2.95E-01 (Median) | Methylation in Control | 1.53E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS1500 (cg09395732) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:4.30E-06; Z-score:-7.24E-01 | ||
Methylation in Case |
7.97E-01 (Median) | Methylation in Control | 8.15E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS1500 (cg18290624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.60E+00 | Statistic Test | p-value:4.56E-06; Z-score:2.68E+00 | ||
Methylation in Case |
2.94E-01 (Median) | Methylation in Control | 1.84E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS1500 (cg00605982) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.32E+00 | Statistic Test | p-value:3.73E-05; Z-score:1.78E+00 | ||
Methylation in Case |
1.90E-01 (Median) | Methylation in Control | 1.45E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS200 (cg26836233) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.29E+00 | Statistic Test | p-value:6.81E-09; Z-score:5.69E+00 | ||
Methylation in Case |
3.78E-01 (Median) | Methylation in Control | 1.65E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS200 (cg21123160) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.49E+00 | Statistic Test | p-value:5.68E-05; Z-score:2.39E+00 | ||
Methylation in Case |
4.84E-01 (Median) | Methylation in Control | 3.25E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
TSS200 (cg22331862) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.40E+00 | Statistic Test | p-value:1.74E-04; Z-score:2.27E+00 | ||
Methylation in Case |
4.86E-01 (Median) | Methylation in Control | 3.48E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
1stExon (cg07830847) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.60E+00 | Statistic Test | p-value:4.04E-17; Z-score:-1.27E+01 | ||
Methylation in Case |
5.34E-01 (Median) | Methylation in Control | 8.55E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg07765706) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.21E+00 | Statistic Test | p-value:2.64E-20; Z-score:-2.24E+01 | ||
Methylation in Case |
4.31E-01 (Median) | Methylation in Control | 9.54E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg14404146) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.20E+00 | Statistic Test | p-value:3.31E-20; Z-score:-8.29E+00 | ||
Methylation in Case |
7.64E-01 (Median) | Methylation in Control | 9.20E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg09355292) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.58E+00 | Statistic Test | p-value:9.13E-20; Z-score:-7.30E+00 | ||
Methylation in Case |
5.06E-01 (Median) | Methylation in Control | 8.01E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon14 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg17864405) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.34E+00 | Statistic Test | p-value:1.76E-17; Z-score:-4.72E+00 | ||
Methylation in Case |
5.96E-01 (Median) | Methylation in Control | 8.01E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon15 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg00704369) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.73E+00 | Statistic Test | p-value:1.21E-16; Z-score:-2.65E+00 | ||
Methylation in Case |
3.63E-01 (Median) | Methylation in Control | 6.27E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon16 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg00309313) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.52E+00 | Statistic Test | p-value:2.20E-15; Z-score:-6.55E+00 | ||
Methylation in Case |
4.85E-01 (Median) | Methylation in Control | 7.35E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon17 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg08903425) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.52E+00 | Statistic Test | p-value:4.61E-15; Z-score:-1.68E+00 | ||
Methylation in Case |
1.98E-01 (Median) | Methylation in Control | 3.02E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon18 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg14788003) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.15E+00 | Statistic Test | p-value:2.30E-08; Z-score:-2.44E+00 | ||
Methylation in Case |
6.19E-01 (Median) | Methylation in Control | 7.13E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon19 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg12461092) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.16E+00 | Statistic Test | p-value:2.52E-06; Z-score:-1.68E+00 | ||
Methylation in Case |
5.69E-01 (Median) | Methylation in Control | 6.60E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon20 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg15284635) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.20E+00 | Statistic Test | p-value:7.03E-06; Z-score:-1.59E+00 | ||
Methylation in Case |
4.26E-01 (Median) | Methylation in Control | 5.13E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon21 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg09660365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.37E+00 | Statistic Test | p-value:7.06E-05; Z-score:2.61E+00 | ||
Methylation in Case |
4.39E-01 (Median) | Methylation in Control | 3.21E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon22 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
Body (cg04746240) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:3.27E-04; Z-score:-9.05E-01 | ||
Methylation in Case |
8.61E-01 (Median) | Methylation in Control | 8.73E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon23 |
Methylation of SLC6A11 in hepatocellular carcinoma | [ 8 ] | |||
Location |
3'UTR (cg20495476) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.56E+00 | Statistic Test | p-value:3.27E-16; Z-score:-4.73E+00 | ||
Methylation in Case |
4.18E-01 (Median) | Methylation in Control | 6.50E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
14 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A11 in HIV infection | [ 9 ] | |||
Location |
TSS1500 (cg07744841) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.57E+00 | Statistic Test | p-value:3.75E-06; Z-score:2.22E+00 | ||
Methylation in Case |
1.81E-01 (Median) | Methylation in Control | 1.15E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A11 in HIV infection | [ 9 ] | |||
Location |
TSS1500 (cg18290624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.37E+00 | Statistic Test | p-value:4.51E-06; Z-score:2.16E+00 | ||
Methylation in Case |
2.55E-01 (Median) | Methylation in Control | 1.86E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC6A11 in HIV infection | [ 9 ] | |||
Location |
TSS1500 (cg00605982) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.26E+00 | Statistic Test | p-value:3.15E-04; Z-score:1.10E+00 | ||
Methylation in Case |
1.73E-01 (Median) | Methylation in Control | 1.37E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC6A11 in HIV infection | [ 9 ] | |||
Location |
TSS200 (cg22331862) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.39E+00 | Statistic Test | p-value:1.07E-07; Z-score:2.53E+00 | ||
Methylation in Case |
4.19E-01 (Median) | Methylation in Control | 3.02E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC6A11 in HIV infection | [ 9 ] | |||
Location |
TSS200 (cg21123160) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.51E+00 | Statistic Test | p-value:1.12E-07; Z-score:2.58E+00 | ||
Methylation in Case |
3.97E-01 (Median) | Methylation in Control | 2.63E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC6A11 in HIV infection | [ 9 ] | |||
Location |
TSS200 (cg10527010) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.93E+00 | Statistic Test | p-value:1.18E-04; Z-score:1.87E+00 | ||
Methylation in Case |
1.32E-01 (Median) | Methylation in Control | 6.82E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC6A11 in HIV infection | [ 9 ] | |||
Location |
TSS200 (cg26836233) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.37E+00 | Statistic Test | p-value:1.39E-04; Z-score:1.10E+00 | ||
Methylation in Case |
1.72E-01 (Median) | Methylation in Control | 1.25E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC6A11 in HIV infection | [ 9 ] | |||
Location |
TSS200 (cg09022422) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:3.06E+00 | Statistic Test | p-value:2.50E-04; Z-score:1.69E+00 | ||
Methylation in Case |
7.50E-02 (Median) | Methylation in Control | 2.45E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC6A11 in HIV infection | [ 9 ] | |||
Location |
1stExon (cg16435571) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.37E+00 | Statistic Test | p-value:6.99E-06; Z-score:2.87E+00 | ||
Methylation in Case |
1.00E-01 (Median) | Methylation in Control | 4.23E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC6A11 in HIV infection | [ 9 ] | |||
Location |
Body (cg09660365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.34E+00 | Statistic Test | p-value:1.60E-06; Z-score:1.64E+00 | ||
Methylation in Case |
3.05E-01 (Median) | Methylation in Control | 2.28E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC6A11 in HIV infection | [ 9 ] | |||
Location |
Body (cg14788003) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:6.04E-06; Z-score:1.49E+00 | ||
Methylation in Case |
6.90E-01 (Median) | Methylation in Control | 6.26E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC6A11 in HIV infection | [ 9 ] | |||
Location |
Body (cg12461092) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.12E+00 | Statistic Test | p-value:2.07E-05; Z-score:-1.98E+00 | ||
Methylation in Case |
7.39E-01 (Median) | Methylation in Control | 8.28E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC6A11 in HIV infection | [ 9 ] | |||
Location |
Body (cg15668533) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.23E+00 | Statistic Test | p-value:1.54E-03; Z-score:1.35E+00 | ||
Methylation in Case |
3.10E-01 (Median) | Methylation in Control | 2.51E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon14 |
Methylation of SLC6A11 in HIV infection | [ 9 ] | |||
Location |
Body (cg15284635) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:2.23E-02; Z-score:3.43E-01 | ||
Methylation in Case |
5.39E-01 (Median) | Methylation in Control | 5.19E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A11 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS1500 (cg00605982) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.76E+00 | Statistic Test | p-value:5.24E-03; Z-score:4.59E+00 | ||
Methylation in Case |
2.85E-01 (Median) | Methylation in Control | 1.62E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A11 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS1500 (cg18290624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.83E+00 | Statistic Test | p-value:5.96E-03; Z-score:7.57E+00 | ||
Methylation in Case |
3.57E-01 (Median) | Methylation in Control | 1.95E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC6A11 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS1500 (cg07744841) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.01E+00 | Statistic Test | p-value:7.64E-03; Z-score:6.11E+00 | ||
Methylation in Case |
3.27E-01 (Median) | Methylation in Control | 1.62E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC6A11 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS200 (cg22331862) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.56E+00 | Statistic Test | p-value:2.28E-03; Z-score:4.18E+00 | ||
Methylation in Case |
4.86E-01 (Median) | Methylation in Control | 3.12E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC6A11 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS200 (cg21123160) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.63E+00 | Statistic Test | p-value:2.59E-03; Z-score:3.60E+00 | ||
Methylation in Case |
4.98E-01 (Median) | Methylation in Control | 3.06E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC6A11 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS200 (cg26836233) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.72E+00 | Statistic Test | p-value:4.86E-03; Z-score:3.83E+00 | ||
Methylation in Case |
3.38E-01 (Median) | Methylation in Control | 1.96E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC6A11 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS200 (cg10527010) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.11E+00 | Statistic Test | p-value:7.37E-03; Z-score:4.56E+00 | ||
Methylation in Case |
2.49E-01 (Median) | Methylation in Control | 1.18E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC6A11 in lung adenocarcinoma | [ 10 ] | |||
Location |
TSS200 (cg09022422) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.63E+00 | Statistic Test | p-value:1.06E-02; Z-score:4.73E+00 | ||
Methylation in Case |
2.10E-01 (Median) | Methylation in Control | 7.99E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC6A11 in lung adenocarcinoma | [ 10 ] | |||
Location |
1stExon (cg16435571) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.07E+00 | Statistic Test | p-value:9.47E-03; Z-score:6.22E+00 | ||
Methylation in Case |
2.12E-01 (Median) | Methylation in Control | 1.03E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC6A11 in lung adenocarcinoma | [ 10 ] | |||
Location |
Body (cg09660365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.67E+00 | Statistic Test | p-value:2.36E-03; Z-score:2.57E+00 | ||
Methylation in Case |
4.18E-01 (Median) | Methylation in Control | 2.50E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC6A11 in lung adenocarcinoma | [ 10 ] | |||
Location |
Body (cg15668533) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.55E+00 | Statistic Test | p-value:6.64E-03; Z-score:2.37E+00 | ||
Methylation in Case |
4.15E-01 (Median) | Methylation in Control | 2.67E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A11 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS1500 (cg18290624) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:7.46E-04; Z-score:6.70E-01 | ||
Methylation in Case |
1.87E-01 (Median) | Methylation in Control | 1.67E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A11 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS1500 (cg07744841) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.22E+00 | Statistic Test | p-value:8.15E-03; Z-score:6.12E-01 | ||
Methylation in Case |
1.29E-01 (Median) | Methylation in Control | 1.06E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC6A11 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS200 (cg21123160) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.54E+00 | Statistic Test | p-value:2.61E-05; Z-score:1.22E+00 | ||
Methylation in Case |
2.50E-01 (Median) | Methylation in Control | 1.63E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC6A11 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS200 (cg22331862) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.25E+00 | Statistic Test | p-value:9.30E-05; Z-score:8.34E-01 | ||
Methylation in Case |
2.52E-01 (Median) | Methylation in Control | 2.02E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC6A11 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS200 (cg09022422) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:3.08E-02; Z-score:2.24E-01 | ||
Methylation in Case |
7.12E-02 (Median) | Methylation in Control | 6.54E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC6A11 in papillary thyroid cancer | [ 11 ] | |||
Location |
1stExon (cg16435571) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.13E+00 | Statistic Test | p-value:2.16E-03; Z-score:3.86E-01 | ||
Methylation in Case |
8.04E-02 (Median) | Methylation in Control | 7.14E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC6A11 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg12461092) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.14E+00 | Statistic Test | p-value:2.97E-09; Z-score:-1.79E+00 | ||
Methylation in Case |
7.06E-01 (Median) | Methylation in Control | 8.06E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC6A11 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg09660365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.13E+00 | Statistic Test | p-value:1.18E-02; Z-score:4.02E-01 | ||
Methylation in Case |
1.92E-01 (Median) | Methylation in Control | 1.71E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC6A11 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg14788003) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:1.24E-02; Z-score:-3.53E-01 | ||
Methylation in Case |
7.52E-01 (Median) | Methylation in Control | 7.71E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC6A11 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg04746240) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:3.48E-02; Z-score:-6.07E-01 | ||
Methylation in Case |
9.39E-01 (Median) | Methylation in Control | 9.46E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A11 in prostate cancer | [ 12 ] | |||
Location |
TSS1500 (cg04139184) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.25E+00 | Statistic Test | p-value:4.38E-02; Z-score:1.76E+00 | ||
Methylation in Case |
8.39E-01 (Median) | Methylation in Control | 6.73E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A11 in prostate cancer | [ 12 ] | |||
Location |
Body (cg01021245) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:4.96E-02; Z-score:1.35E+00 | ||
Methylation in Case |
9.30E-01 (Median) | Methylation in Control | 8.91E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A11 in panic disorder | [ 13 ] | |||
Location |
TSS200 (cg26836233) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-9.48E-01 | Statistic Test | p-value:7.94E-03; Z-score:-3.22E-01 | ||
Methylation in Case |
-3.65E+00 (Median) | Methylation in Control | -3.46E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A11 in panic disorder | [ 13 ] | |||
Location |
TSS200 (cg10527010) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-9.51E-01 | Statistic Test | p-value:2.63E-02; Z-score:-2.96E-01 | ||
Methylation in Case |
-4.84E+00 (Median) | Methylation in Control | -4.60E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC6A11 in panic disorder | [ 13 ] | |||
Location |
TSS200 (cg22331862) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-8.89E-01 | Statistic Test | p-value:4.89E-02; Z-score:-4.67E-01 | ||
Methylation in Case |
-1.65E+00 (Median) | Methylation in Control | -1.47E+00 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A11 in atypical teratoid rhabdoid tumor | [ 14 ] | |||
Location |
1stExon (cg16435571) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.37E+00 | Statistic Test | p-value:5.20E-18; Z-score:-2.48E+00 | ||
Methylation in Case |
5.77E-01 (Median) | Methylation in Control | 7.93E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC6A11 in atypical teratoid rhabdoid tumor | [ 14 ] | |||
Location |
Body (cg04746240) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:9.39E-04; Z-score:6.33E-01 | ||
Methylation in Case |
8.77E-01 (Median) | Methylation in Control | 7.80E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC6A11 in atypical teratoid rhabdoid tumor | [ 14 ] | |||
Location |
Body (cg09660365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.54E+00 | Statistic Test | p-value:1.16E-02; Z-score:-3.32E-01 | ||
Methylation in Case |
7.06E-02 (Median) | Methylation in Control | 1.09E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC6A11 in atypical teratoid rhabdoid tumor | [ 14 ] | |||
Location |
Body (cg12461092) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:2.78E-02; Z-score:-2.44E-01 | ||
Methylation in Case |
8.52E-01 (Median) | Methylation in Control | 8.58E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Depression |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC6A11 in depression | [ 15 ] | |||
Location |
Body (cg15668533) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:4.07E-02; Z-score:6.58E-01 | ||
Methylation in Case |
2.06E-01 (Median) | Methylation in Control | 1.84E-01 (Median) | ||
Studied Phenotype |
Depression[ ICD-11:6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.